NCT04060849View on ClinicalTrials.gov

Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY

PHASE1TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

April 12, 2020

Study Completion Date

April 12, 2020

Conditions
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSolid Neoplasm
Interventions
DRUG

Nozin

Given via nasal single-use popswabs or single-use cotton tipped applicators

OTHER

Best Practice

Receive standard of care

Trial Locations (2)

60462

University of Chicago Medicine-Orland Park, Orland Park

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

Sponsors
All Listed Sponsors
collaborator

Global Life Technologies Corp.

UNKNOWN

lead

Fred Hutchinson Cancer Center

OTHER